1. Home
  2. TRML vs YRD Comparison

TRML vs YRD Comparison

Compare TRML & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRML
  • YRD
  • Stock Information
  • Founded
  • TRML 2021
  • YRD 2012
  • Country
  • TRML United States
  • YRD China
  • Employees
  • TRML N/A
  • YRD N/A
  • Industry
  • TRML Biotechnology: Pharmaceutical Preparations
  • YRD Finance: Consumer Services
  • Sector
  • TRML Health Care
  • YRD Finance
  • Exchange
  • TRML Nasdaq
  • YRD Nasdaq
  • Market Cap
  • TRML 419.1M
  • YRD 402.3M
  • IPO Year
  • TRML N/A
  • YRD 2015
  • Fundamental
  • Price
  • TRML $27.66
  • YRD $6.58
  • Analyst Decision
  • TRML Strong Buy
  • YRD
  • Analyst Count
  • TRML 3
  • YRD 0
  • Target Price
  • TRML $64.67
  • YRD N/A
  • AVG Volume (30 Days)
  • TRML 202.3K
  • YRD 163.1K
  • Earning Date
  • TRML 11-07-2024
  • YRD 11-19-2024
  • Dividend Yield
  • TRML N/A
  • YRD 3.10%
  • EPS Growth
  • TRML N/A
  • YRD 20.30
  • EPS
  • TRML N/A
  • YRD 3.15
  • Revenue
  • TRML N/A
  • YRD $751,311,287.00
  • Revenue This Year
  • TRML N/A
  • YRD N/A
  • Revenue Next Year
  • TRML N/A
  • YRD N/A
  • P/E Ratio
  • TRML N/A
  • YRD $1.89
  • Revenue Growth
  • TRML N/A
  • YRD 28.79
  • 52 Week Low
  • TRML $12.12
  • YRD $2.19
  • 52 Week High
  • TRML $48.31
  • YRD $9.20
  • Technical
  • Relative Strength Index (RSI)
  • TRML 58.78
  • YRD 55.58
  • Support Level
  • TRML $25.10
  • YRD $5.85
  • Resistance Level
  • TRML $28.35
  • YRD $6.27
  • Average True Range (ATR)
  • TRML 1.37
  • YRD 0.33
  • MACD
  • TRML -0.26
  • YRD 0.00
  • Stochastic Oscillator
  • TRML 57.98
  • YRD 75.00

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an advanced, AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

Share on Social Networks: